TIAA CREF Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$467K Sell
2018
Q4
$916K Sell
2018
Q3
$2.65M Sell
2018
Q2
$4.09M Buy
2018
Q1
$3.55M Hold
2017
Q4
$5M Sell
2017
Q3
$5.94M Buy
2017
Q2
$5.83M Buy
2017
Q1
$5.32M Sell
2016
Q4
$4.87M Buy
2016
Q3
$728 Hold
2016
Q2
$525K Buy
2016
Q1
$245K Hold
2015
Q4
$349K Buy